ANI Pharmaceuticals
ANIP
HK$531.63
Share price
1.77%
Change (1 day)
-2.49%
Change (1 year)
Categories
P/S ratio for ANI Pharmaceuticals (ANIP)
P/S ratio as of March 2025 (TTM): 2.42
According to ANI Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.47. At the end of 2024 the company had a P/S ratio of 1.86.
P/S ratio history for ANI Pharmaceuticals from 2001 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 1.86 | -19.55% |
| 2023 | 2.31 | 4.25% |
| 2022 | 2.22 | -37.55% |
| 2021 | 3.55 | 106.33% |
| 2020 | 1.72 | -52.33% |
| 2019 | 3.61 | 36.37% |
| 2018 | 2.65 | -37.62% |
| 2017 | 4.25 | -22.25% |
| 2016 | 5.46 | -19.72% |
| 2015 | 6.80 | -40.75% |
| 2014 | 11.5 | 46.48% |
| 2013 | 7.84 | -40.11% |
| 2012 | 13.1 | -89.69% |
| 2011 | 127 | 134.16% |
| 2010 | 54.2 | -12.34% |
| 2009 | 61.8 | 748.33% |
| 2008 | 7.29 | -96.5% |
| 2007 | 208 | 4549.39% |
| 2006 | 4.48 | -98.36% |
| 2005 | 274 | -79.87% |
| 2004 | > 1000 | 4366.23% |
| 2003 | 30.5 | 383.09% |
| 2002 | 6.31 | -78.89% |
| 2001 | 29.9 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 1.95 | -19.33% | 🇮🇪 Ireland |
 | 0.4989 | -79.39% | 🇺🇸 USA |
 | 1.08 | -55.55% | 🇮🇱 Israel |
 | 2.25 | -7.20% | 🇺🇸 USA |
 | 0.0238 | -99.02% | 🇺🇸 USA |
 | 189 | 7,702.66% | 🇺🇸 USA |
 | 0.1486 | -93.86% | 🇺🇸 USA |
 | 4.25 | 75.68% | 🇨🇭 Switzerland |
 | 8.04 | 231.91% | 🇬🇧 UK |